Using Gene Transfer Technology to Restore the Salivary Gland Function in Xerostomia Patients following Radiation Therapy of Head and Neck Cancer

Autores

  • Sabah Hassan Faculty of Dentistry, Al-Mansour University College, Baghdad, Iraq.

DOI:

https://doi.org/10.5195/d3000.2024.744

Palavras-chave:

Head and Neck Cancer, Gene Therapy, Saliva, Salivary Gland

Resumo

Many diseases can be treated by gene therapy using a modified virus to carry the corrected required gene to infect the target cells. The goal of this report is presenting the planning for gene therapy for patients suffering from head and neck cancer to alleviate their loss of saliva function.

Referências

Yoruk O, Seven B, Varoglu E, Ucuncu H, Sahin A, Ayan AK, Sutbeyaz Y, Tozoglu S. Evaluation of salivary gland function in allergic rhinitis patients by [99mTc] pertechnetate salivary gland scintigraphy. Central European Journal of Medicine. 2010;5(2):246-250. DOI: 10.2478/s11536-009-0041-6.

Chen Y-C, Chen H-Y, Hsu C-H. Recent advances in salivary scintigraphic evaluation of salivary gland function. Diagnostics. 2021;11:1173. https://doi.org/10.3390/diagnostics11071173.

Downloads

Publicado

2024-11-22

Edição

Seção

Mechanisms of Oral Disease